MBX Biosciences, Inc.
MBX
$8.70
$0.070.81%
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
--
Headlines
3/13/2025
-
Simply Wall St
3/5/2025
-
The Fly
3/5/2025
-
GuruFocus
3/5/2025
-
Globe Newswire
3/5/2025
-
MarketBeat
3/3/2025
-
TipRanks Financial Blog
3/3/2025
-
The Fly
3/3/2025
-
Globe Newswire
2/21/2025
-
GuruFocus
2/21/2025
-
MarketBeat
2/21/2025
-
MarketBeat
2/20/2025
-
MarketBeat
2/20/2025
-
MarketBeat
2/18/2025
-
GuruFocus
2/18/2025
-
Globe Newswire
2/6/2025
-
MarketBeat
1/23/2025
-
GuruFocus
1/23/2025
-
Globe Newswire
1/7/2025
-
MarketBeat
1/7/2025
-
Benzinga
1/7/2025
-
TipRanks Financial Blog
1/7/2025
-
The Fly
1/7/2025
-
GuruFocus
1/7/2025
-
Globe Newswire
1/3/2025
-
MarketBeat
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
--
Net Income (TTM)
--
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
--
Cash from Investing (TTM)
--
Cash from Financing (TTM)
--
Net Change in Cash (TTM)
--
Filings
Filing Date
Thursday, November 7, 2024
Period Date
Monday, September 30, 2024
Next Filing
Week of Jul 7 and 11 (est)
Price History
Beta
--
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
--
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
(317) 659-0200
Address
11711 N. Meridian Street
Carmel, IN 46032
Carmel, IN 46032
Country
Year Founded
Business Description
Sector
MBX Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision peptide therapies for the treatment of endocrine and metabolic disorders...
more
